Index of reports
> Cases with Disseminated Intravascular Coagulation (16)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Metastron (Strontium Chloride, SR-89) where reactions include disseminated intravascular coagulation. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Metastron side effects in male
Reported by a physician from Japan on 2012-03-23
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Disseminated Intravascular Coagulation, Platelet Count Decreased, Bone Marrow Failure
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Prednisolone (Predonine); Ketoprofen; Arnica Montana Tincture (Doc)
Possible Metastron side effects in male
Reported by a physician from Japan on 2012-03-23
Patient: male, weighing 53.0 kg (116.6 pounds)
Reactions: Disseminated Intravascular Coagulation, Anaemia, Thrombocytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Prednisolone; Docetaxel
Possible Metastron side effects in male
Reported by a physician from Japan on 2012-03-08
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: White Blood Cell Count Decreased, Disseminated Intravascular Coagulation, Anaemia, Platelet Count Decreased
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Ketoprofen; Prednisolone (Predonine); Arnica Montana Tincture (Doc)
Possible Metastron side effects in male
Reported by a physician from Japan on 2012-03-08
Patient: male, weighing 53.0 kg (116.6 pounds)
Reactions: Disseminated Intravascular Coagulation, Anaemia, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Docetaxel; Prednisolone
Possible Metastron side effects in female
Reported by a physician from Japan on 2012-03-07
Patient: female
Reactions: Death, Hepatic Function Abnormal, Disseminated Intravascular Coagulation, Lung Neoplasm Malignant, Neoplasm Progression, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Metastron
Possible Metastron side effects in male
Reported by a physician from Japan on 2012-02-24
Patient: male, weighing 53.0 kg (116.6 pounds)
Reactions: Anaemia, Disseminated Intravascular Coagulation, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Docetaxel; Prednisolone
Possible Metastron side effects in 59 year old female
Reported by a physician from Japan on 2012-02-21
Patient: 59 year old female
Reactions: White Blood Cell Count Decreased, Disseminated Intravascular Coagulation
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Metastron
Indication: Metastatic Pain
Start date: 2011-11-10
End date: 2011-11-10
Metastron
Indication: Therapeutic Procedure
Other drugs received by patient: Zometa; Loxoprofen Sodium Hydrate; Docetaxel; Capecitabine
Possible Metastron side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-25
Patient: 59 year old female
Reactions: Disseminated Intravascular Coagulation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Zoledronic Acid (Zometa) (Zoledronic Acid); Loxoprofen Sodium Hydrate (Loxoprofen); Capecitabine
Possible Metastron side effects in 61 year old male
Reported by a individual with unspecified qualification from Japan on 2012-01-19
Patient: 61 year old male
Reactions: Disseminated Intravascular Coagulation, Anaemia, Platelet Count Decreased, Neoplasm Progression, Bladder Cancer
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Zoledronic Acid Hydrate (Zoledronic Acid); Oxycodone HCL; Etodolac
Possible Metastron side effects in 69 year old male
Reported by a individual with unspecified qualification from Japan on 2012-01-19
Patient: 69 year old male, weighing 71.0 kg (156.2 pounds)
Reactions: Anaemia, Disseminated Intravascular Coagulation, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Oxycodone HCL; Levofloxacin; Gabexate (Gabexate)
Possible Metastron side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-03
Patient: 59 year old female
Reactions: Disseminated Intravascular Coagulation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Loxoprofen Sodium Hydrate (Loxoprofen); Zoledronic Acid (Zometa) (Zoledronic Acid)
Possible Metastron side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-03
Patient: 69 year old male, weighing 71.0 kg (156.2 pounds)
Reactions: Anaemia, Disseminated Intravascular Coagulation, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Metastron
Possible Metastron side effects in male
Reported by a individual with unspecified qualification from Japan on 2011-12-20
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Disseminated Intravascular Coagulation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Possible Metastron side effects in 61 year old male
Reported by a individual with unspecified qualification from Japan on 2011-12-05
Patient: 61 year old male
Reactions: Disseminated Intravascular Coagulation, Bone Marrow Failure, Disease Progression
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Oxycodone HCL; Zoledronic Acid Hydrate (Zoledronic Acid); Etodolac
Possible Metastron side effects in 39 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-15
Patient: 39 year old female
Reactions: Disseminated Intravascular Coagulation, Cerebral Haemorrhage
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: Cbdca (Carboplatin); Taxol; UFT (Uftoral); Zometa; Cyclophosphamide Hydrate (Cyclophosphamdie Hydrate); GEM (Omeprazole)
Possible Metastron side effects in 39 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-10
Patient: 39 year old female
Reactions: Disseminated Intravascular Coagulation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Metastron
Other drugs received by patient: GEM (Omeprazole); Zometa; Taxol; Cyclophosphamide Hydrate (Cyclophosphamide Monohydrate); UFT (Uftoral); Cbdca (Carboplatin)
|